Equanil suspension

Equanil suspension Brand names, Equanil suspension Analogs

Equanil suspension Brand Names Mixture

No information avaliable

Equanil suspension Chemical_Formula

C₂₀H₂₃NS

Equanil suspension RX_link

No information avaliable

Equanil suspension fda sheet

Equanil suspension msds (material safety sheet)

Equanil suspension Synthesis Reference

No information avaliable

Equanil suspension Molecular Weight

309.469 g/mol

Equanil suspension Melting Point

< 25 ^oC

Equanil suspension H₂O Solubility

Soluble as HCl salt

Equanil suspension State

Liquid

Equanil suspension LogP

5.7

Equanil suspension Dosage Forms

Tablets (oral, 1 mg)

Equanil suspension Indication

Used for the symptomatic treatment of parkinsonism.

Equanil suspension Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Equanil suspension Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Equanil suspension side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Equanil suspension Patient Information

Equanil suspension Organisms Affected

Humans and other mammals